Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Filamon LTD
Fred Hutchinson Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
University of California, Davis
M.D. Anderson Cancer Center
Peking University Cancer Hospital & Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
ViroMissile, Inc.
Replimune Inc.
Washington University School of Medicine
University of Florida
Pfizer
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
Essen Biotech
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Novartis
Daiichi Sankyo
University of Nebraska
M.D. Anderson Cancer Center
Second Life Therapeutics
NRG Oncology
M.D. Anderson Cancer Center
AgonOx, Inc.
Novartis
Elephas
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University Health Network, Toronto
Petrov, Andrey
AstraZeneca
Revolution Medicines, Inc.
Tempus AI
Virginia Commonwealth University
British Columbia Cancer Agency
Travera Inc
National Institutes of Health Clinical Center (CC)
Guangzhou FineImmune Biotechnology Co., LTD.
Obsidian Therapeutics, Inc.
Mayo Clinic
Washington University School of Medicine
University of Florida